Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

Delayed Data
As of Jan 22
 +0.16 / +0.28%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 30 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 52.56, with a high estimate of 64.81 and a low estimate of 32.18. The median estimate represents a -9.30% decrease from the last price of 57.95.

Analyst Recommendations

The current consensus among 32 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since January, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.41%
Growthannually 16.67%


Growthquarterly 9.43%
Growthannually 12.91%
Key to the earnings and sales forecast charts.